Nadir Arber

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Hiv Infected Patients

Top Venues

EMBO molecular medicine

Cancer prevention research (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Shiran Shapira, Marina Ben Shimon, Mori Hay-Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev-Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond. EMBO molecular medicine 14 (9) (2022)
Meghna S Trivedi, Nadir Arber, Eitan Friedman, Judy E Garber, Kevin Holcomb, Neil S Horowitz, Jason D Wright, Jiun-Kae Jack Lee, Lana A Vornik, Saba Abutaseh, Tawana Castile, Edward R Sauter, Eileen Dimond, Brandy M Heckman-Stoddard, Margaret House, Goli Samimi, Powel H Brown, Katherine D Crew
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer prevention research (Philadelphia, Pa.) 15 (11) (2022)
Shiran Shapira, Ilana Boustanai, Dina Kazanov, Marina Ben Shimon, Ahmad Fokra, Nadir Arber
Innovative dual system approach for selective eradication of cancer cells using viral-based delivery of natural bacterial toxin-antitoxin system. Oncogene 40 (31) (2021)
Shiran Shapira, Eynat Finkelshtein, Dina Kazanov, Esmira Naftali, Irena Stepansky, Abraham Loyter, Daniel Elbirt, Mori Hay-Levy, Eli Brazowski, Faina Bedny, Roy Dekel, Dov Hershkovitz, Arye Blachar, Ido Wolf, Nadir Arber
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells. Oncogene 40 (22) (2021)